Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunological abnormalities and hydantoins.

P J Grob, G E Herold

    British Medical Journal
    |June 3, 1972
    PubMed
    Summary
    This summary is machine-generated.

    Prolonged hydantoin use in epilepsy patients may impair humoral immunity, indicated by low Immunoglobulin A (IgA) and beta(1)C/A levels. This contrasts with cellular immunity, which is typically unaffected by such treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Altered intracellular expression of the chemokines MIP-1alpha, MIP-1beta and IL-8 by peripheral blood CD4+ and CD8+ T cells in mild allergic asthma.

    Allergy·2003
    Same author

    [Hepatitis B virus infection: diagnosis, clinical sequelae, therapy and prevention].

    Praxis·2002
    Same author

    Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection.

    Journal of acquired immune deficiency syndromes (1999)·2001
    Same author

    [Hepatitis C virus infection. Overview. SEVHEP (Swiss Experts on Viral Hepatitis)].

    Praxis·2000
    Same author

    Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study Group.

    AIDS (London, England)·1999
    Same author

    Hepatitis B: virus, pathogenesis and treatment.

    Vaccine·1999
    Same journal

    Muscular pain during therapy with carbenoxolone (Biogastrone).

    British medical journal·2016
    Same journal

    ACUTE INTESTINAL OBSTRUCTION DUE TO INTRA-ABDOMINAL CAUSES.

    British medical journal·2014
    Same journal

    A CASE OF HAEMATIDROSIS.

    British medical journal·2014
    Same journal

    Incidence of ulcer in haematemesis.

    British medical journal·2011
    Same journal

    Pituitary hypothyroidism with impaired renal function.

    British medical journal·2011
    Same journal

    The fenestration operation for otosclerosis.

    British medical journal·2011
    See all related articles

    Area of Science:

    • Immunology
    • Neurology
    • Pharmacology

    Background:

    • Epilepsy treatment often involves long-term medication.
    • Hydantoin anticonvulsants are commonly prescribed for epilepsy management.
    • Potential side effects of long-term drug use on the immune system require investigation.

    Purpose of the Study:

    • To investigate the impact of prolonged hydantoin treatment on immunological features in epilepsy patients.
    • To differentiate the effects of hydantoins on humoral versus cellular immunity.

    Main Methods:

    • Measurement of various immunological parameters in 20 epilepsy patients on long-term hydantoins.
    • Assessment of Immunoglobulin A (IgA) and beta(1)C/A levels.
    • Skin testing and dinitrochlorobenzene sensitization tests were performed.

    Related Experiment Videos

  • Comparison with 14 control epilepsy patients not on hydantoins.

    • Main Results:

    • Five patients on hydantoins had absent or low Immunoglobulin A (IgA).
    • Ten patients exhibited low beta(1)C/A levels.
    • Impaired cellular immunity was observed in some patients (negative skin tests, failed sensitization).
    • Immunological features were normal in the control group.

    Conclusions:

    • Prolonged hydantoin therapy appears to influence humoral immunity in epilepsy patients.
    • Hydantoins may lead to deficiencies in Immunoglobulin A (IgA) and complement components.
    • Findings suggest a distinct immunomodulatory profile for hydantoins compared to other immunosuppressants affecting cellular immunity.